Suppr超能文献

Silexan for treatment of anxiety and depression in the context of COVID-19.

作者信息

Bartova Lucie, Dold Markus, Fugger Gernot, Weidenauer Ana, Rujescu Dan, Kasper Siegfried

机构信息

Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.

Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria; Psychiatric Day Hospital, University Hospital St. Poelten, St. Poelten, Austria; Karl Landsteiner Private University of Health Sciences, Krems an der Donau, Austria.

出版信息

Eur Neuropsychopharmacol. 2023 May;70:47-48. doi: 10.1016/j.euroneuro.2023.02.015. Epub 2023 Feb 23.

DOI:10.1016/j.euroneuro.2023.02.015
PMID:36867894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9946880/
Abstract
摘要

相似文献

1
Silexan for treatment of anxiety and depression in the context of COVID-19.
Eur Neuropsychopharmacol. 2023 May;70:47-48. doi: 10.1016/j.euroneuro.2023.02.015. Epub 2023 Feb 23.
2
Efficacy of Silexan in mixed anxiety-depression--A randomized, placebo-controlled trial.
Eur Neuropsychopharmacol. 2016 Feb;26(2):331-340. doi: 10.1016/j.euroneuro.2015.12.002. Epub 2015 Dec 12.
3
Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender.
Neurochem Int. 2021 Feb;143:104899. doi: 10.1016/j.neuint.2020.104899. Epub 2020 Nov 9.
4
An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review.
Int J Psychiatry Clin Pract. 2013 Nov;17 Suppl 1:15-22. doi: 10.3109/13651501.2013.813555. Epub 2013 Aug 3.
5
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial.
Int Clin Psychopharmacol. 2010 Sep;25(5):277-87. doi: 10.1097/YIC.0b013e32833b3242.
6
A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
Phytomedicine. 2010 Feb;17(2):94-9. doi: 10.1016/j.phymed.2009.10.006. Epub 2009 Dec 3.
7
Lavender Oil Preparation (Silexan) for Treating Anxiety: An Updated Meta-Analysis.
J Clin Psychopharmacol. 2017 Feb;37(1):115-117. doi: 10.1097/JCP.0000000000000615.
8
Silexan in anxiety disorders: Clinical data and pharmacological background.
World J Biol Psychiatry. 2018 Sep;19(6):412-420. doi: 10.1080/15622975.2017.1331046. Epub 2017 Jun 19.
9
Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan.
Int J Psychiatry Clin Pract. 2023 Sep;27(3):285-291. doi: 10.1080/13651501.2023.2187308. Epub 2023 Apr 6.
10
Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials.
Eur Arch Psychiatry Clin Neurosci. 2019 Mar;269(2):183-193. doi: 10.1007/s00406-017-0852-4. Epub 2017 Nov 17.

引用本文的文献

1
Silexan in anxiety, depression, and related disorders: pharmacological background and clinical data.
Eur Arch Psychiatry Clin Neurosci. 2024 Oct 25. doi: 10.1007/s00406-024-01923-8.
2
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea.
J Neural Transm (Vienna). 2024 Mar;131(3):203-212. doi: 10.1007/s00702-024-02749-3. Epub 2024 Feb 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验